Reiko Isa - Division of Hematology and Oncology, Kyoto Prefectural University of Medicine

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 28 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Anti-Myeloma Efficacy of TAS0612, a Triple Inhibitor of RSK, AKT, and S6K, and Itssynergistic Combination with Venetoclax in Multiple Myeloma Irrespective of Cytogeneticabnormalities

Haruya Okamoto,Shinsuke Mizutani,Taku Tsukamoto,Yoko Katsuragawa-Taminishi,Yuka Kawaji-Kanayama,Kentaro Mizuhara,Ayako Muramatsu,Reiko Isa,Takahiro Fujino,Yuji Shimura, Koji Ichikawa,Junya Kuroda

Bloodno. Supplement 1 (2024): 4178-4178

引用0浏览0引用

Prognostic Model for Relapsed/refractory Transplant-Ineligible Diffuse Large B-cell Lymphoma Utilizing the Lymphocyte-to-monocyte Ratio

Daisuke Ide,Takahiro Fujino,Tsutomu Kobayashi, Aya Egashira,Akihiro Miyashita,Kentaro Mizuhara,Reiko Isa,Taku Tsukamoto,Shinsuke Mizutani,Hitoji Uchiyama,Hiroto Kaneko,Nobuhiko Uoshima,Eri Kawata,Masafumi Taniwaki,Yuji Shimura,Junya Kuroda

International Journal of Hematologyno. 6 (2024): 697-706

引用0浏览0WOS引用

Robust Anti-Myeloma Effect of TAS0612, an RSK/AKT/S6K Inhibitor, with Venetoclax Regardless of Cytogenetic Abnormalities

Haruya Okamoto,Shinsuke Mizutani,Taku Tsukamoto,Yoko Katsuragawa-Taminishi,Yuka Kawaji-Kanayama,Kentaro Mizuhara,Ayako Muramatsu,Reiko Isa,Takahiro Fujino,Yuji Shimura, Koji Ichikawa,Junya Kuroda

Leukemiano. 1 (2024): 211-221

引用0浏览0WOSNATURE引用

P1226: BTG2, A NOVEL TARGET OF MIR-17-92, REGULATES B CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA

Yuka Kawaji-Kanayama,Taku Tsukamoto,Masakazu Nakano,Yuichi Tokuda,Hiroaki Nagata,Kentaro Mizuhara,Yoko Katsuragawa-Taminishi,Reiko Isa,Takahiro Fujino,Yayoi Matsumura-Kimoto,Shinsuke Mizutani,Yuji Shimura,Masafumi Taniwaki,Kei Tashiro,Junya Kuroda

HemaSphereno. S3 (2023)

引用0浏览0引用

The Universal Antitumor Activity of TAS0612, a Triple Inhibitor for RSK, AKT, and S6K, in B-Cell Lymphomas Regardless of Disease Subtype

Yoko Katsuragawa-Taminishi,Shinsuke Mizutani,Yuka Kawaji-Kanayama,Akio Onishi,Haruya Okamoto,Reiko Isa,Kentaro Mizuhara,Ayako Muramatsu,Takahiro Fujino,Taku Tsukamoto,Yuji Shimura,Masafumi Taniwaki,Aya Miyagawa-Hayashino,Eiichi Konishi,Junya Kuroda

BLOOD (2023)

引用0浏览0引用

Mir-17-92 Cluster-Btg2 Axis Regulates B-cell Receptor Signaling in Mantle Cell Lymphoma

Cancer Science（2023）

引用0浏览0引用

TAS0612, a Triple Inhibitor for RSK, AKT, and S6K, is a Promising Anti-Myeloma Agent Regardless of Types of Cytogenetic/Genetic Abnormality

Haruya Okamoto,Shinsuke Mizutani,Taku Tsukamoto,Yoko Katsuragawa-Taminishi,Reiko Isa,Kentaro Mizuhara,Ayako Muramatsu,Yuka Kawaji-Kanayama,Takahiro Fujino,Yuji Shimura,Junya Kuroda

BLOOD (2023)

引用0浏览0引用

Triple Targeting of RSK, AKT, and S6K As Pivotal Downstream Effectors of PDPK1 by TAS0612 in B‐cell Lymphomas

CANCER SCIENCEno. 12 (2023): 4691-4705

引用0浏览0WOS引用

Mir-106a-5p and Mir-146a-5p Delivered by Tumor-Derived Exosomes Promote the Induction of Myeloid-Derived Suppressor Cells from Normal Peripheral Blood Mononuclear Cells in Multiple Myeloma

Kentaro Mizuhara,Yuji Shimura,Taku Tsukamoto,Akinori Kanai,Saeko Kuwahara-Ota,Junko Yamaguchi,Ayako Muramatsu,Haruya Okamoto,Yoko Taminishi-Katsuragawa,Yuka Kawaji-Kanayama,Reiko Isa,Shinsuke Mizutani,Toshiya Inaba,Junya Kuroda

BRITISH JOURNAL OF HAEMATOLOGY（2023）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn